Neuropsychiatric Aspects in a Patient Diagnosed with Corticobasal Degeneration: Clinical Case of Low Incidence and Prevalence in Colombia

La degeneración corticobasal (CBD) es una patología de baja incidencia y prevalencia en todo el mundo; eso se acompaña de síntomas como distonía, síndrome acinético rígido (bradicinesia), marcha alteraciones, deterioro neurológico asociado con atrofia subcortical cortical severa, y déficits neurocog...

Full description

Autores:: Hurtado González, Carlos Alberto
Vivas Álzate, Diana
Marmolejo Escobar, Carlos Steven
Arango de la Pava, Pablo Miguel
Díaz Varela, Daniela
Allin Ramírez, Danny Vanesa
Hernández, Viviana
SEMINEC
CINEPSIS

Tipo de recurso:: Article of investigation

Fecha de publicación:: 2020

Institución:: Universidad Cooperativa de Colombia

Repositorio:: Repositorio UCC

Idioma:

id	COOPER2_589e33cb8b3962890cba5b4095116890
oai_identifier_str	oai:repository.ucc.edu.co:20.500.12494/33683
network_acronym_str	COOPER2
network_name_str	Repositorio UCC
repository_id_str
dc.title.spa.fl_str_mv	Neuropsychiatric Aspects in a Patient Diagnosed with Corticobasal Degeneration: Clinical Case of Low Incidence and Prevalence in Colombia
title	Neuropsychiatric Aspects in a Patient Diagnosed with Corticobasal Degeneration: Clinical Case of Low Incidence and Prevalence in Colombia
spellingShingle	Neuropsychiatric Aspects in a Patient Diagnosed with Corticobasal Degeneration: Clinical Case of Low Incidence and Prevalence in Colombia Atención Degeneración corticobasal Funcionamiento neurocognitivo Funciones ejecutivas Memoria Lóbulo frontal Attention Corticobasal degeneration Neurocognitive functioning Executive functions Memory Frontal lobe
title_short	Neuropsychiatric Aspects in a Patient Diagnosed with Corticobasal Degeneration: Clinical Case of Low Incidence and Prevalence in Colombia
title_full	Neuropsychiatric Aspects in a Patient Diagnosed with Corticobasal Degeneration: Clinical Case of Low Incidence and Prevalence in Colombia
title_fullStr	Neuropsychiatric Aspects in a Patient Diagnosed with Corticobasal Degeneration: Clinical Case of Low Incidence and Prevalence in Colombia
title_full_unstemmed	Neuropsychiatric Aspects in a Patient Diagnosed with Corticobasal Degeneration: Clinical Case of Low Incidence and Prevalence in Colombia
title_sort	Neuropsychiatric Aspects in a Patient Diagnosed with Corticobasal Degeneration: Clinical Case of Low Incidence and Prevalence in Colombia
dc.creator.fl_str_mv	Hurtado González, Carlos Alberto Vivas Álzate, Diana Marmolejo Escobar, Carlos Steven Arango de la Pava, Pablo Miguel Díaz Varela, Daniela Allin Ramírez, Danny Vanesa Hernández, Viviana SEMINEC CINEPSIS
dc.contributor.author.none.fl_str_mv	Hurtado González, Carlos Alberto Vivas Álzate, Diana Marmolejo Escobar, Carlos Steven Arango de la Pava, Pablo Miguel Díaz Varela, Daniela Allin Ramírez, Danny Vanesa Hernández, Viviana SEMINEC CINEPSIS
dc.subject.spa.fl_str_mv	Atención Degeneración corticobasal Funcionamiento neurocognitivo Funciones ejecutivas Memoria Lóbulo frontal
topic	Atención Degeneración corticobasal Funcionamiento neurocognitivo Funciones ejecutivas Memoria Lóbulo frontal Attention Corticobasal degeneration Neurocognitive functioning Executive functions Memory Frontal lobe
dc.subject.other.spa.fl_str_mv	Attention Corticobasal degeneration Neurocognitive functioning Executive functions Memory Frontal lobe
description	La degeneración corticobasal (CBD) es una patología de baja incidencia y prevalencia en todo el mundo; eso se acompaña de síntomas como distonía, síndrome acinético rígido (bradicinesia), marcha alteraciones, deterioro neurológico asociado con atrofia subcortical cortical severa, y déficits neurocognitivos progresivos a moderados a severos, especialmente en memoria y síndrome dorsolateral o disejecutivo. Identificamos deterioro neurocognitivo y síntomas neuropsiquiátricos en un paciente diagnosticado con CBD. La participante era una paciente de 70 años, soltera; Ella presentó pérdida progresiva de la memoria de un lenguaje verbal inmediato. naturaleza. Inicialmente, le diagnosticaron enfermedad de Alzheimer y demencia con cuerpos de Lewy, y encontró que no presentaba signos y síntomas característicos de estas patologías. El paciente presentó conciliación insomnio, alteraciones de la marcha y déficit neurocognitivo severo, especialmente en las funciones ejecutivas, memoria verbal inmediata y funcionamiento visuoespacial. Se encontró que el El paciente presentó alteraciones neurocognitivas de tipo ejecutivo (lóbulo frontal) como toma de decisiones, planificación, inhibición y memoria operativa, correlacionadas con una alteración severa en sus actividades básicas, instrumentales y avanzadas de la vida diaria, con alto factor de riesgo para desarrollar demencia. Es necesario diagnosticar de manera asertiva y oportuna para generar planes de neurorrehabilitación funcional en personas diagnosticadas de CBD, con el objetivo principal de impactando positivamente la calidad de vida, a nivel individual, familiar y social.
publishDate	2020
dc.date.issued.none.fl_str_mv	2020
dc.date.accessioned.none.fl_str_mv	2021-03-19T20:26:04Z
dc.date.available.none.fl_str_mv	2021-03-19T20:26:04Z
dc.type.none.fl_str_mv	Artículos Científicos
dc.type.hasVersion.none.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.coar.none.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.none.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.none.fl_str_mv	info:eu-repo/semantics/article
format	http://purl.org/coar/resource_type/c_2df8fbb1
status_str	publishedVersion
dc.identifier.uri.spa.fl_str_mv	10.1159/000509073
dc.identifier.uri.none.fl_str_mv	https://hdl.handle.net/20.500.12494/33683
dc.identifier.bibliographicCitation.spa.fl_str_mv	Hurtado González C, A, Piedrahita C, Vivas Álzate D, García Borrero J, J, Marmolejo Escobar C, S, Ospina Otalvaro S, Arango P, M, Gutiérrez Lenis P, A, Varela D, D, Molano E, L, Allin Ramírez D, V, Rinco A, Sánchez J, Hernández V: Neuropsychiatric Aspects in a Patient Diagnosed with Corticobasal Degeneration: Clinical Case of Low Incidence and Prevalence in Colombia. Case Rep Neurol 2020;12:387-401. doi: 10.1159/000509073
identifier_str_mv	10.1159/000509073 Hurtado González C, A, Piedrahita C, Vivas Álzate D, García Borrero J, J, Marmolejo Escobar C, S, Ospina Otalvaro S, Arango P, M, Gutiérrez Lenis P, A, Varela D, D, Molano E, L, Allin Ramírez D, V, Rinco A, Sánchez J, Hernández V: Neuropsychiatric Aspects in a Patient Diagnosed with Corticobasal Degeneration: Clinical Case of Low Incidence and Prevalence in Colombia. Case Rep Neurol 2020;12:387-401. doi: 10.1159/000509073
url	https://hdl.handle.net/20.500.12494/33683
dc.relation.isversionof.spa.fl_str_mv	https://www.karger.com/Article/Abstract/509073#
dc.relation.ispartofjournal.spa.fl_str_mv	Case Reports in Neurology
dc.relation.references.spa.fl_str_mv	Babcock H. An experiment in the measurement of mental deterioration. Arch Psychol. 1930;117:105. Baquero M, Martín N. Depressive symptoms in neurodegenerative diseases. World J Clin Cases. 2015;3(8):682. https://doi.org/10.12998/wjcc.v3.i8.682. Beck A, Steer R. Manual BAI. Inventario de Ansiedad de Beck (adaptación española de J. Sanz). 2011. Cacho-Gutierrez LJ, García-García R, Arcaya-Navarro J, Lantada N. Una propuesta de aplicación del test del reloj en la enfermedad de Alzheimer. Rev Neurol. 1999;28:648–55. Cummings JL, Victoroff JI. Noncognitive neuropsychiatric syndromes in Alzheimer’s disease. Neuropsychiatry Neuropsychol Behav Neurol. 1990;3(2):140-158. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: A frontal assessment battery at bedside. Neurology. 2000 Dec;55(11):1621-6. Kertesz A, McMonagle P. Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy. J Neurol Sci. 210;289(1-2):138-143. https://doi.org/10.1016/j.jns.2009.08.036 Lawton MP, Brody EM, Saperstein AR. A controlled study of respite service for caregivers of Alzheimer’s patients. Gerontologist. 1989 Feb;29(1):8–16. Levin J, Kurz A, Arzberger T, Giese A, Höglinger GU. The Differential Diagnosis and Treatment of Atypical Parkinsonism. Dtsch Arztebl Int. 2016 Feb;113(5):61–9. Lobo A, Pérez-Echeverría MJ, Artal J. Validity of the scaled version of the General Health Questionnaire (GHQ-28) in a Spanish population. Psychol Med. 1986 Feb;16(1):135–40. Lobo A, Saz P, Marcos G; Grupo ZARAMDEMP. Mini-Mental Status Examination. Madrid: Tea ediciones; 2001. Mahoney F, Barthel DW. FUNCTIONAL EVALUATION: THE BARTHEL INDEX. Md State Med J. 1965 Feb;14:61-5. Moretti R, Torre P, Antonello RM, Cattaruzza T, Cazzato G. Cognitive impairment in the lateralized phenotype of corticobasal degeneration. Dement Geriatr Cogn Disord. 2005;20(2-3):158–62. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9. https://doi.org/10.1111/j.1532-5415.2005.53221.x. Oliveira LM, Barcellos I, Teive HA, Munhoz RP. Cognitive dysfunction in corticobasal degeneration [Internet]. Arq Neuropsiquiatr. 2017 Aug;75(8):570–9. [cited 2020 May 02] Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2017000800570&lng=en Reitan RM. Trail Making Test: Manual for administration and scoring. Tempe: Reitan Neuropsychology Laboratory; 1992. Stamelou M, Kailash B. Dementia in Parkinson’s Disease and Atypical Parkinsonism. Movement Disorders in Dementias. London: Springer; 2014. pp 179–97. Wenning GK, Litvan I, Jankovic J, Granata R, Mangone CA, McKee A, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry. 1998 Feb;64(2):184–9. Weschsler D. Weschsler Memory Scale. New York: The Psychological Corporation; 1972. Yesavage JA, Sheikh JI. 9/Geriatric depression scale (GDS) recent evidence and development of a shorter version. Clin Gerontol. 1986;5(1-2):165–73.
dc.rights.license.none.fl_str_mv	NINGUNA
dc.rights.accessrights.none.fl_str_mv	info:eu-repo/semantics/closedAccess
dc.rights.coar.none.fl_str_mv	http://purl.org/coar/access_right/c_14cb
rights_invalid_str_mv	NINGUNA http://purl.org/coar/access_right/c_14cb
eu_rights_str_mv	closedAccess
dc.format.extent.spa.fl_str_mv	387-401 p.
dc.coverage.temporal.spa.fl_str_mv	12
dc.publisher.spa.fl_str_mv	Corticobasal degeneration (CBD) is a pathology of low incidence and prevalence worldwide; it is accompanied by symptoms such as dystonia, rigid akinetic syndrome (bradykinesia), gait disturbances, neurological deterioration associated with severe cortical subcortical atrophy, and progressive to moderate to severe neurocognitive deficits, especially in immediate verbal memory and dorsolateral or dysexecutive syndrome. We identified neurocognitive impairment and neuropsychiatric symptoms in a patient diagnosed with CBD. Participant was a 70-yearold female patient, single; she presented progressive memory loss of an immediate verbal nature. Initially, she was diagnosed with Alzheimer’s disease and Lewy body dementia, finding that she had no characteristic signs and symptoms of these pathologies. The patient presented conciliation insomnia, gait disturbances, and severe neurocognitive deficit, especially in executive functions, immediate verbal memory, and visuospatial functioning. It was found that the patient presented neurocognitive alterations of the executive type (frontal lobe) such as decision making, planning, inhibition and operative memory, correlated with a severe alteration in her basic, instrumental and advanced activities of daily life, with a high risk factor for developing dementia. It is necessary to diagnose in an assertive and timely manner in order to generate functional neurorehabilitation plans in people diagnosed with CBD, with the main objective of positively impacting quality of life, at the individual, family, and social level.
dc.publisher.program.spa.fl_str_mv	Psicología
dc.publisher.place.spa.fl_str_mv	Cali
institution	Universidad Cooperativa de Colombia
bitstream.url.fl_str_mv	https://repository.ucc.edu.co/bitstreams/f91a0f86-be95-4295-b33b-a59ec7b7b952/download https://repository.ucc.edu.co/bitstreams/6237c77c-04bb-493f-bde7-ed336c9ef9d5/download https://repository.ucc.edu.co/bitstreams/dedaea7f-7b90-46c3-a83c-22a7b59e99c3/download https://repository.ucc.edu.co/bitstreams/0a565ece-966c-44ce-9c80-156551b27b03/download
bitstream.checksum.fl_str_mv	3bce4f7ab09dfc588f126e1e36e98a45 248e58c0edb1741dca31aeaf8a04396e d8b45ecce7eefb5a53c4e0c88b51cbb4 8f309b489d2eeaad24e1c74a6147b661
bitstream.checksumAlgorithm.fl_str_mv	MD5 MD5 MD5 MD5
repository.name.fl_str_mv	Repositorio Institucional Universidad Cooperativa de Colombia
repository.mail.fl_str_mv	bdigital@metabiblioteca.com
_version_	1811564924571222016
spelling	Hurtado González, Carlos AlbertoVivas Álzate, DianaMarmolejo Escobar, Carlos StevenArango de la Pava, Pablo Miguel Díaz Varela, DanielaAllin Ramírez, Danny VanesaHernández, VivianaSEMINECCINEPSIS122021-03-19T20:26:04Z2021-03-19T20:26:04Z202010.1159/000509073https://hdl.handle.net/20.500.12494/33683Hurtado González C, A, Piedrahita C, Vivas Álzate D, García Borrero J, J, Marmolejo Escobar C, S, Ospina Otalvaro S, Arango P, M, Gutiérrez Lenis P, A, Varela D, D, Molano E, L, Allin Ramírez D, V, Rinco A, Sánchez J, Hernández V: Neuropsychiatric Aspects in a Patient Diagnosed with Corticobasal Degeneration: Clinical Case of Low Incidence and Prevalence in Colombia. Case Rep Neurol 2020;12:387-401. doi: 10.1159/000509073La degeneración corticobasal (CBD) es una patología de baja incidencia y prevalencia en todo el mundo; eso se acompaña de síntomas como distonía, síndrome acinético rígido (bradicinesia), marcha alteraciones, deterioro neurológico asociado con atrofia subcortical cortical severa, y déficits neurocognitivos progresivos a moderados a severos, especialmente en memoria y síndrome dorsolateral o disejecutivo. Identificamos deterioro neurocognitivo y síntomas neuropsiquiátricos en un paciente diagnosticado con CBD. La participante era una paciente de 70 años, soltera; Ella presentó pérdida progresiva de la memoria de un lenguaje verbal inmediato. naturaleza. Inicialmente, le diagnosticaron enfermedad de Alzheimer y demencia con cuerpos de Lewy, y encontró que no presentaba signos y síntomas característicos de estas patologías. El paciente presentó conciliación insomnio, alteraciones de la marcha y déficit neurocognitivo severo, especialmente en las funciones ejecutivas, memoria verbal inmediata y funcionamiento visuoespacial. Se encontró que el El paciente presentó alteraciones neurocognitivas de tipo ejecutivo (lóbulo frontal) como toma de decisiones, planificación, inhibición y memoria operativa, correlacionadas con una alteración severa en sus actividades básicas, instrumentales y avanzadas de la vida diaria, con alto factor de riesgo para desarrollar demencia. Es necesario diagnosticar de manera asertiva y oportuna para generar planes de neurorrehabilitación funcional en personas diagnosticadas de CBD, con el objetivo principal de impactando positivamente la calidad de vida, a nivel individual, familiar y social.Corticobasal degeneration (CBD) is a pathology of low incidence and prevalence worldwide; it is accompanied by symptoms such as dystonia, rigid akinetic syndrome (bradykinesia), gait disturbances, neurological deterioration associated with severe cortical subcortical atrophy, and progressive to moderate to severe neurocognitive deficits, especially in immediate verbal memory and dorsolateral or dysexecutive syndrome. We identified neurocognitive impairment and neuropsychiatric symptoms in a patient diagnosed with CBD. Participant was a 70-yearold female patient, single; she presented progressive memory loss of an immediate verbal nature. Initially, she was diagnosed with Alzheimer’s disease and Lewy body dementia, finding that she had no characteristic signs and symptoms of these pathologies. The patient presented conciliation insomnia, gait disturbances, and severe neurocognitive deficit, especially in executive functions, immediate verbal memory, and visuospatial functioning. It was found that the patient presented neurocognitive alterations of the executive type (frontal lobe) such as decision making, planning, inhibition and operative memory, correlated with a severe alteration in her basic, instrumental and advanced activities of daily life, with a high risk factor for developing dementia. It is necessary to diagnose in an assertive and timely manner in order to generate functional neurorehabilitation plans in people diagnosed with CBD, with the main objective of positively impacting quality of life, at the individual, family, and social level.carlos.hurtadog@campusucc.edu.co387-401 p.Corticobasal degeneration (CBD) is a pathology of low incidence and prevalence worldwide; it is accompanied by symptoms such as dystonia, rigid akinetic syndrome (bradykinesia), gait disturbances, neurological deterioration associated with severe cortical subcortical atrophy, and progressive to moderate to severe neurocognitive deficits, especially in immediate verbal memory and dorsolateral or dysexecutive syndrome. We identified neurocognitive impairment and neuropsychiatric symptoms in a patient diagnosed with CBD. Participant was a 70-yearold female patient, single; she presented progressive memory loss of an immediate verbal nature. Initially, she was diagnosed with Alzheimer’s disease and Lewy body dementia, finding that she had no characteristic signs and symptoms of these pathologies. The patient presented conciliation insomnia, gait disturbances, and severe neurocognitive deficit, especially in executive functions, immediate verbal memory, and visuospatial functioning. It was found that the patient presented neurocognitive alterations of the executive type (frontal lobe) such as decision making, planning, inhibition and operative memory, correlated with a severe alteration in her basic, instrumental and advanced activities of daily life, with a high risk factor for developing dementia. It is necessary to diagnose in an assertive and timely manner in order to generate functional neurorehabilitation plans in people diagnosed with CBD, with the main objective of positively impacting quality of life, at the individual, family, and social level.PsicologíaCalihttps://www.karger.com/Article/Abstract/509073#Case Reports in NeurologyBabcock H. An experiment in the measurement of mental deterioration. Arch Psychol. 1930;117:105.Baquero M, Martín N. Depressive symptoms in neurodegenerative diseases. World J Clin Cases. 2015;3(8):682. https://doi.org/10.12998/wjcc.v3.i8.682.Beck A, Steer R. Manual BAI. Inventario de Ansiedad de Beck (adaptación española de J. Sanz). 2011.Cacho-Gutierrez LJ, García-García R, Arcaya-Navarro J, Lantada N. Una propuesta de aplicación del test del reloj en la enfermedad de Alzheimer. Rev Neurol. 1999;28:648–55.Cummings JL, Victoroff JI. Noncognitive neuropsychiatric syndromes in Alzheimer’s disease. Neuropsychiatry Neuropsychol Behav Neurol. 1990;3(2):140-158.Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: A frontal assessment battery at bedside. Neurology. 2000 Dec;55(11):1621-6.Kertesz A, McMonagle P. Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy. J Neurol Sci. 210;289(1-2):138-143. https://doi.org/10.1016/j.jns.2009.08.036Lawton MP, Brody EM, Saperstein AR. A controlled study of respite service for caregivers of Alzheimer’s patients. Gerontologist. 1989 Feb;29(1):8–16.Levin J, Kurz A, Arzberger T, Giese A, Höglinger GU. The Differential Diagnosis and Treatment of Atypical Parkinsonism. Dtsch Arztebl Int. 2016 Feb;113(5):61–9.Lobo A, Pérez-Echeverría MJ, Artal J. Validity of the scaled version of the General Health Questionnaire (GHQ-28) in a Spanish population. Psychol Med. 1986 Feb;16(1):135–40.Lobo A, Saz P, Marcos G; Grupo ZARAMDEMP. Mini-Mental Status Examination. Madrid: Tea ediciones; 2001.Mahoney F, Barthel DW. FUNCTIONAL EVALUATION: THE BARTHEL INDEX. Md State Med J. 1965 Feb;14:61-5.Moretti R, Torre P, Antonello RM, Cattaruzza T, Cazzato G. Cognitive impairment in the lateralized phenotype of corticobasal degeneration. Dement Geriatr Cogn Disord. 2005;20(2-3):158–62.Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9. https://doi.org/10.1111/j.1532-5415.2005.53221.x.Oliveira LM, Barcellos I, Teive HA, Munhoz RP. Cognitive dysfunction in corticobasal degeneration [Internet]. Arq Neuropsiquiatr. 2017 Aug;75(8):570–9. [cited 2020 May 02] Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2017000800570&lng=enReitan RM. Trail Making Test: Manual for administration and scoring. Tempe: Reitan Neuropsychology Laboratory; 1992.Stamelou M, Kailash B. Dementia in Parkinson’s Disease and Atypical Parkinsonism. Movement Disorders in Dementias. London: Springer; 2014. pp 179–97.Wenning GK, Litvan I, Jankovic J, Granata R, Mangone CA, McKee A, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry. 1998 Feb;64(2):184–9.Weschsler D. Weschsler Memory Scale. New York: The Psychological Corporation; 1972.Yesavage JA, Sheikh JI. 9/Geriatric depression scale (GDS) recent evidence and development of a shorter version. Clin Gerontol. 1986;5(1-2):165–73.AtenciónDegeneración corticobasalFuncionamiento neurocognitivoFunciones ejecutivasMemoriaLóbulo frontalAttentionCorticobasal degenerationNeurocognitive functioningExecutive functionsMemoryFrontal lobeNeuropsychiatric Aspects in a Patient Diagnosed with Corticobasal Degeneration: Clinical Case of Low Incidence and Prevalence in ColombiaArtículos Científicosinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_2df8fbb1http://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleNINGUNAinfo:eu-repo/semantics/closedAccesshttp://purl.org/coar/access_right/c_14cbPublicationLICENSElicense.txtlicense.txttext/plain; charset=utf-84334https://repository.ucc.edu.co/bitstreams/f91a0f86-be95-4295-b33b-a59ec7b7b952/download3bce4f7ab09dfc588f126e1e36e98a45MD52ORIGINAL2020_neuropsychiatric_aspects.pdf2020_neuropsychiatric_aspects.pdfArtículoapplication/pdf534871https://repository.ucc.edu.co/bitstreams/6237c77c-04bb-493f-bde7-ed336c9ef9d5/download248e58c0edb1741dca31aeaf8a04396eMD51THUMBNAIL2020_neuropsychiatric_aspects.pdf.jpg2020_neuropsychiatric_aspects.pdf.jpgGenerated Thumbnailimage/jpeg5098https://repository.ucc.edu.co/bitstreams/dedaea7f-7b90-46c3-a83c-22a7b59e99c3/downloadd8b45ecce7eefb5a53c4e0c88b51cbb4MD53TEXT2020_neuropsychiatric_aspects.pdf.txt2020_neuropsychiatric_aspects.pdf.txtExtracted texttext/plain39014https://repository.ucc.edu.co/bitstreams/0a565ece-966c-44ce-9c80-156551b27b03/download8f309b489d2eeaad24e1c74a6147b661MD5420.500.12494/33683oai:repository.ucc.edu.co:20.500.12494/336832024-08-10 09:35:15.025restrictedhttps://repository.ucc.edu.coRepositorio Institucional Universidad Cooperativa de Colombiabdigital@metabiblioteca.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

Neuropsychiatric Aspects in a Patient Diagnosed with Corticobasal Degeneration: Clinical Case of Low Incidence and Prevalence in Colombia

Publicaciones similares